| Bioactivity | HIV-1 protease-IN-10 (Compound 2) has HIV-1 latency reversing activity (IC50: 0.22 μM). HIV-1 protease-IN-10 binds to the PKCδ C1b domain (IC50: 0.69 μM). HIV-1 protease-IN-10 has stability against esterase-mediated hydrolysis[1]. |
| Name | HIV-1 protease-IN-10 |
| Formula | C23H40O5 |
| Molar Mass | 396.56 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Ishii T, et al. Synthesis and evaluation of DAG-lactone derivatives with HIV-1 latency reversing activity. Eur J Med Chem. 2023 Aug 5;256:115449. |
HIV-1 protease-IN-10
CAS: F: C23H40O5 W: 396.56
HIV-1 protease-IN-10 (Compound 2) has HIV-1 latency reversing activity (IC50: 0.22 μM). HIV-1 protease-IN-10 binds to t
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.